Evidence map›Paper›PMID 41714361›Full record

ArticleEMBO reports2026

Epigenetic regulation of serine biosynthesis by PHF8 during neurogenesis.

Marta H Artes, Simona Iacobucci, María J Barallobre, Paula Carballeira, Marta Garcia-Cajide, Alejandro Pérez-Venteo, Natalia Padilla, Bárbara S Viegas, Aitana Díaz-Vásquez, A Silvina Nacht and 7 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Marta H Artes *Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, 08028, Spain.ORCID 0000-0001-9268-8452
Simona Iacobucci *Instituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, 08028, Spain.ORCID 0000-0001-5940-0568
María J BarallobreInstituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, 08028, Spain.
Paula CarballeiraDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Madrid, 28049, Spain.ORCID 0009-0008-2721-6377
Marta Garcia-CajideDepartament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Alejandro Pérez-VenteoDepartament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Natalia PadillaVall d'Hebron Institute of Research (VHIR), Passeig de la Vall d'Hebron, 119, E-08035, Barcelona, Spain.ORCID 0000-0002-7872-2279
Bárbara S ViegasInstituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, 08028, Spain.ORCID 0009-0004-6964-9796
Aitana Díaz-VásquezVall d'Hebron Institute of Research (VHIR), Passeig de la Vall d'Hebron, 119, E-08035, Barcelona, Spain.ORCID 0009-0009-6248-4032
A Silvina NachtCenter for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Barcelona, Spain.
Guillermo P VicentInstituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, 08028, Spain.ORCID 0000-0002-0554-2226
Maria L ArbonésInstituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, 08028, Spain.
Xavier de la CruzVall d'Hebron Institute of Research (VHIR), Passeig de la Vall d'Hebron, 119, E-08035, Barcelona, Spain.
Marta NietoDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Madrid, 28049, Spain.ORCID 0000-0002-8349-8435
Neus AgellDepartament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0002-1205-6074
Caroline MauvezinDepartament de Biomedicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.ORCID 0000-0003-4220-7272
Marian A Martínez-BalbásInstituto de Biología Molecular de Barcelona (IBMB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, 08028, Spain. mmbbmc@ibmb.csic.es.ORCID 0000-0003-0173-0964

Funding

Consejo Superior de Investigaciones Científicas (CSIC) 021AEP079Fundación Científica Asociación Española Contra el Cáncer (AECC) LABAE222994MAUVMEC | Spanish National Plan for Scientific and Technical Research and Innovation (Plan Estatal de Investigación Científica y Técnica y de Innovación) AEI/10.13039/501100011033MEC | Spanish National Plan for Scientific and Technical Research and Innovation (Plan Estatal de Investigación Científica y Técnica y de Innovación) PGC2018-096082-B-I00MEC | Spanish National Plan for Scientific and Technical Research and Innovation (Plan Estatal de Investigación Científica y Técnica y de Innovación) PID2020-118768RJ-I00MEC | Spanish National Plan for Scientific and Technical Research and Innovation (Plan Estatal de Investigación Científica y Técnica y de Innovación) PID2021-125862NB-I00MEC | Spanish National Plan for Scientific and Technical Research and Innovation (Plan Estatal de Investigación Científica y Técnica y de Innovación) PID2022-138728OB-I00MEC | Spanish National Plan for Scientific and Technical Research and Innovation (Plan Estatal de Investigación Científica y Técnica y de Innovación) RYC2022-035576-IUniversitat de Barcelona (UB) PREDOC-UB 2022
6 · The paper itself

Abstract

Progenitor proliferation during neurodevelopment requires tight coordination of epigenetic regulation and metabolism. However, the crosstalk between these processes remains poorly understood. To investigate this, we examine in neural stem cells the role of PHF8, a histone demethylase whose mutations are linked to Siderius-Hamel syndrome, a rare neurodevelopmental disorder. Through an integrated multi-omics approach - combining transcriptomics, epigenomics, and metabolomics - we identify PHF8 as a key driver of the serine biosynthesis pathway, safeguarding the intracellular serine pool essential for neural progenitor proliferation. PHF8 fine-tunes chromatin accessibility at promoters of metabolic genes, ensuring their activation during development. Loss of PHF8 disrupts amino acid metabolism, blocks autophagy, and hinders vesicle formation. Ultimately PHF8 depletion leads to replication defects, DNA damage, and proliferation arrest. In vivo, PHF8 deficiency in mouse embryos halts neurogenesis, progenitor expansion, and neuron generation in the developing brain. These findings identify PHF8 as a key molecular link between chromatin regulation, metabolic control, and neural development, offering new insights into the epigenetic basis of neurodevelopmental and metabolic disorders.

Indexed as

Epigenesis, GeneticHistone DemethylasesNeurogenesisSerineTranscription FactorsAnimalsCell ProliferationChromatinGene Expression Regulation, DevelopmentalHumansMiceNeural Stem CellsNeurodevelopmentChromatinHistone DemethylasesPHF8 protein, mouseSerineTranscription FactorsGene TranscriptionNeural Stem CellsNeurogenesisPHF8Serine Biosynthesis Histone Demethylation

Identifiers

PMID41714361
PMCPMC13022353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.